How one vaccine maker responded to a question about RFK Jr. as health secretary
RFK Jr. would rattle health markets as head of HHS, but his confirmation is far from certain, analyst says
Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS
Powell says Fed doesn’t need to hurry to cut interest rates
Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug
Off-price retailers could thrive, BofA says, citing this bullish data point
Republicans clinch control of House, setting stage for quicker action on extending tax cuts
This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho
